JP Patent

JP3845455B2 — 新規な置換フェニルイミダゾリジン、それらの製造法、それらの薬剤としての使用及びそれらを含有する製薬組成物

Assigned to アベンティス・ファーマ・ソシエテ・アノニム · Expires 2006-11-15 · 20y expired

What this patent protects

Patent listed against Xtandi.

Drugs covered by this patent

Patent Metadata

Patent number
JP3845455B2
Jurisdiction
JP
Classification
—
Expires
2006-11-15
Drug substance claim
No
Drug product claim
No
Assignee
アベンティス・ファーマ・ソシエテ・アノニム
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.